Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 24, Number 6—June 2018

Research

Frequent Implication of Multistress-Tolerant Campylobacter jejuni in Human Infections

Euna Oh, Linda Chui, Junghee Bae, Vincent Li, Angela Ma, Steven K. Mutschall, Eduardo N. Taboada, Lynn M. McMullen, and Byeonghwa JeonComments to Author 
Author affiliations: University of Alberta School of Public Health, Edmonton, Alberta, Canada (E. Oh, J. Bae, B. Jeon); Provincial Laboratory for Public Health in Alberta, Canada, Edmonton (L. Chui, V. Li); University of Alberta, Edmonton (L. Chui, A. Ma, L.M. McMullen); Public Health Agency of Canada, Lethbridge, Alberta, Canada (S.K. Mutschall, E.N. Taboada)

Main Article

Figure 5

Increased stress tolerance and prevalence of multistress-tolerant (MST) clades of Camplyobacter jejuni. A) Augmented tolerance of MST clades to 5 stressors (aeration, disinfectant [PAA], freeze-thaw, heat, and salt). Clades are arranged in the order of decreasing levels of overall stress tolerance. B) Top 10 most prevalent CGF subtypes in the CGF collection of human clinical strains of C. jejuni in Alberta, Canada, during 2006–2008 (n = 281) and 2016–May 2017 (n = 229). 1, 0044.003.001; 2, 0169.

Figure 5. Increased stress tolerance and prevalence of multistress-tolerant (MST) clades of Camplyobacter jejuni. A) Augmented tolerance of MST clades to 5 stressors (aeration, disinfectant [PAA], freeze-thaw, heat, and salt). Clades are arranged in the order of decreasing levels of overall stress tolerance. B) Top 10 most prevalent CGF subtypes in the CGF collection of human clinical strains of C. jejuni in Alberta, Canada, during 2006–2008 (n = 281) and 2016–May 2017 (n = 229). 1, 0044.003.001; 2, 0169.001.002; 3, 0083.001.002; 4, 0695.006.001; 5, 0083.007.001; 6, 0269.004.001; 7, 0253.004.001; 8. 0123.002.001; 9, 0173.004.001; 10, 0882.002.002. C) Cumulative prevalence of the CGF subtypes belonging to MST clades in the CGF collection of human clinical strains of C. jejuni in Alberta, Canada, during 2006–2008 (n = 281) and 2016–May 2017 (n = 229). AT, aerotolerant; CGF, comparative genomic fingerprinting; HAT, hyperaerotolerant; OS, oxygen sensitive; PAA, peracetic acid.

Main Article

Page created: May 17, 2018
Page updated: May 17, 2018
Page reviewed: May 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external